Side-by-side comparison of AI visibility scores, market position, and capabilities
FY2024 Revenue: $4.923B (+6.47% YoY) | Global RevPAR +3.0% | 59,100 rooms opened (371 hotels, record) | Net system growth: 7.1% | Luxury RevPAR +5.4% | Resort RevPAR +6.2% | Management/franchise fees dominant business model
InterContinental is a luxury hotel brand offering upscale accommodations and sophisticated experiences in major cities and resort destinations worldwide. The company serves affluent business and leisure travelers who expect premium amenities, exceptional service, and distinctive properties that reflect local culture and character. InterContinental has maintained its position as a leading luxury brand through iconic properties in prestigious locations, personalized concierge services, fine dining, extensive meeting facilities, and the IHG Rewards loyalty program that appeals to discerning travelers seeking elevated hospitality experiences.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.